Article Listing - Merck & Co's Rizatriptan Approved In Holland

GERMAN CALL FOR MORE CONTROL OF ACCESS

20 April 1992

German citizens with state health insurance coverage should in future be entitled to access to a medical specialist only after...

AESGP 1992 MEETING IN BARCELONA

20 April 1992

The European Proprietary Medicines Manufacturers' Association, the AESGP, is to hold its 28th annual meeting at the Hotel Princesa Sofia...

HUHTAMAKI OPTIMISM FOR 1991 VINDICATED

20 April 1992

Finland's Huhtamaki said a year ago that it was "cautiously optimistic" about 1991 in the face of the rapidly-worsening situation,...

SINGAPORE DENIES US TRADE CHARGES

20 April 1992

Singapore's Ministry of Trade and Industry has described as "misleading and inaccurate" charges of unfair trade practices which have been...

J&J IN STOCK REPURCHASE

20 April 1992

Johnson & Johnson is to repurchase up to $500 million of its outstanding common stock for corporate purposes. The company...

ROCHE AND XENOVA CD4 DRUG DEAL

20 April 1992

Swiss major Hoffmann-La Roche Ltd and its US subsidiary Hoffmann-La Roche Inc have entered into a license agreement with the...

HYDRO PHARMA TAKEOVER

20 April 1992

Norwegian pharmaceutical concern Hafslund Nycomed, through its subsidiary Nycomed Pharma, has finalized the takeover of Hydro Pharma (Marketletter February 24)...

L'OREAL 1991 RESULTS

20 April 1992

Fench cosmetics company L'Oreal, majority shareholder of the French pharmaceutical concern Synthelabo, posted net profits for 1991 of just over...

JANSSEN'S CISAPRIDE IN USA

20 April 1992

An advisory committee to the US Food and Drug Administra-tion has recommended approval of Janssen's cisapride, a gastro-esophageal reflux disease...

HAFSLUND NYCOMED'S CONTRAST AGENT

20 April 1992

Hafslund Nycomed is seeking approval in a number of countries to market a non-ionic X-ray contrast agent called Iodixanol. The...

Showing 94451-94460 of 95572 articles